Richard A. Larson to Patient Reported Outcome Measures
This is a "connection" page, showing publications Richard A. Larson has written about Patient Reported Outcome Measures.
Connection Strength
0.079
-
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors. J Natl Cancer Inst. 2022 01 11; 114(1):160-164.
Score: 0.045
-
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. BMC Cancer. 2018 04 02; 18(1):359.
Score: 0.034